US & Canada, Jan. 24, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, “Infusion Devices Market Size and Forecast (2021 - 2031), Global and Regional Share ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $5.00.

Launched in 2018, the Morningstar Minority Empowerment Index highlights companies that demonstrate a strong commitment to ...

One significant area of research has been the effect of central venous pressure on fluid delivery during the start-up of syringe infusion pumps. A study found that varying central venous pressure ...

Meet Verdoie, a new luxury Parisian beauty brand that puts mushrooms in the forefront of its formulas. This moisturizing ...

Ypsomed Holding AG (0QLQ – Research Report) received a Buy rating and a CHF400.00 price target from UBS analyst Tanya Hansalik today. The ...

This story is part of NBC Select’s New & Notable column, where we highlight our favorite product launches. We will ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Plasma-derived therapies are essential for treating a wide range of conditions, including immune deficiencies, bleeding ...

In addition, the company offers medical devices and machines, such as cardiovascular ultrasounds; needless connectors and IV lines; and ambulatory/PCA infusion pumps for critical care, anti ...